Cardiotoxicity Induced by Chemotherapy and Antibody Therapy
- 1 February 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 57 (1), 485-498
- https://doi.org/10.1146/annurev.med.57.121304.131240
Abstract
Modern cancer therapy employs a combination of chemotherapy, antibody-based therapy, radiotherapy, and surgery to prolong life and provide cure. However, many of the chemotherapy agents and antibodies, either singly or in combination, can affect the cardiovascular system. Common cardiovascular manifestations of these therapies include heart failure, ischemia, hypotension, hypertension, edema, QT prolongation, bradyarrhythmia, and thromboembolism. The patient's age, underlying cardiovascular status, and genetic background, as well as the route of drug administration and dosage, can all contribute to the development of cardiotoxicity. Strategies to monitor for and to manage these effects are discussed in this review.Keywords
This publication has 57 references indexed in Scilit:
- Cardiovascular Complications of Cancer TherapyCirculation, 2004
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Thalidomide as initial therapy for early-stage myelomaLeukemia, 2003
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaThe New England Journal of Medicine, 2002
- Clinical Experience of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaThe Oncologist, 2001
- Klinische Wirksamkeit und Ausblicke für die Anwendung von pegyliertem liposomalem Doxorubicin bei der Behandlung von Ovarial- und MammakarzinomenDrugs, 1997
- Acute Coronary Events Following Cisplatin-Based ChemotherapyCancer Investigation, 1990
- Early detection of doxorubicin cardiotoxicity: Interest of Doppler echocardiographic analysis of left ventricular filling dynamicsAmerican Heart Journal, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987